Chapter 2 Continuation

Specialty Boards

• Specialty boards will be created, subject to accreditation by the Board and the PRC.

Prerequisite for Practice of Pharmacy

• Sets minimum age and examination requirements.

Sale of Medicine, Pharmaceuticals, Drugs, and Devices

• Requires a prescription drugstore or hospital pharmacy to compound and dispense medicines following GCP.

Filling and Refilling of Prescription

• Requires a prescriber's order for refills and a registered pharmacist for filling prescriptions.

Label of Dispensed Medicine

• Specifies required information on dispensed medicine labels under RA 5921 and RA 10918.

Recording of Patient Medication Profile

• Lists required information for patient medication profiles.

Record Books for Prescription

• Mandates record-keeping for prescriptions, dangerous drugs, and referrals.

Prescription Switching and Use of Cipher and Unusual Terms

• Prohibits prescriptions written in ciphers and drug substitutions without consent.

Disposal of Medications and Other Pharmacy Documents with Patient Protected Health Information (PHI)

• Requires pharmacists to coordinate with suppliers for disposal and protect patient privacy.

RA 3720: Food, Drug, and Cosmetics Act

• Ensures the safety and purity of food, drugs, and cosmetics.

FDA Powers/Duties

• Lists the powers and duties of the FDA, including inspection, analysis, and standard setting.

Section 11

• Prohibits the sale of adulterated or misbranded products.

Section 18

• Defines conditions under which drugs are deemed adulterated.

Section 19

• Defines when a drug is considered misbranded.

Section 21

• Requires pre-market approval for new drugs to ensure safety and efficacy.

RA 6675: Generics Act of 1988

• Promotes the use of generic drugs.

RA 7581: Price Act

• Protects consumers by stabilizing prices of basic necessities during emergencies.

Important Terms

• Defines Automatic Price Control and Mandated Price Ceiling.

Legal Acts of Price Manipulation

• Defines hoarding, profiteering, and cartels.

RA 8203: Special Law on Counterfeit Drugs

• Prohibits counterfeit drugs and provides penalties.

Section 3. Definition of Terms

• Defines counterfeit drugs in detail.

Counterfeit Drugs shall also refer to

• Includes drugs with false trademarks, refilled containers, unregistered imports, and incorrect active ingredients.

Section 4. Prohibited Acts

• Lists prohibited acts related to counterfeit drugs.

RA 9165: Comprehensive Dangerous Drugs Act of 2002

• Addresses trafficking and use of dangerous drugs.

Section 5. Sale, Trading, Administration, Dispensation, Delivery, Distribution, and Transportation of Dangerous Drugs and/or Controlled Precursors and Essential Chemicals

• Specifies penalties for drug-related offenses.

Maximum Penalty

• Highlights maximum penalties for transactions near schools and drug pushers involving minors.

Section 18. Unnecessary Prescription of Dangerous Drugs

• Addresses penalties for inappropriate prescriptions.

Section 20. Confiscation and Forfeiture of the Proceeds or Instruments of the Unlawful Act, Including the Properties or Proceeds Derived from the Illegal Trafficking of Dangerous Drugs and/or Precursors and Essential Chemicals

• Defines the use of confiscated proceeds.

Section 26. Attempt or Conspiracy

• Penalizes attempts or conspiracies related to drug offenses.

Article IX - Dangerous Drugs Board and Philippine Drug Enforcement Agency

• Establishes the Dangerous Drugs Board and the Philippine Drug Enforcement Agency.

Section 77. Dangerous Drugs Board

• Describes the role of the Dangerous Drugs Board.

Section 78. Composition of the Board

• Lists the members of the Board.

PDEA

• Defines the role of the PDEA in enforcing drug laws.

Article III - Dangerous Drugs Test and Record Requirements

• Requires pharmacists to maintain records of dangerous drug transactions